other material
confidence high
sentiment negative
materiality 0.85
Accelerate Diagnostics, Inc: auditor change — Accelerate Diagnostics restates 2022 quarterly reports; notes misclassification, going concern doubt
Accelerate Diagnostics, Inc
- Restating Q1-Q3 2022 interim financials due to misclassification of $56.6M of 2.50% Senior Convertible Notes as non-current liability.
- Previously issued $171.5M notes; exchanged $114.9M for stock, promissory note, and warrants between Sep 2021 and Aug 2022.
- Amended 10-Qs will include disclosure expressing substantial doubt about ability to continue as a going concern.
- Management expects to report material weakness in internal control over financial reporting for affected periods.
- Restatement does not materially impact statements of operations, cash flows, or stockholders' deficit.